CureVac raised €22M in a Series B round in Jan 2006. The company is based in T√ºbingen, Germany. Investors in the round: DH Capital. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €22M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
